Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_assertion type Assertion NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_head.
- NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_assertion description "[These results suggested that CTLA-4 +49 A/G polymorphism does not contribute to susceptibility to HSP; however, the presence of CTLA-4 AG genotype and HLA-DRB1*13 could be a risk factor for developing nephrotic-range proteinuria in these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_provenance.
- NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_assertion evidence source_evidence_literature NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_provenance.
- NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_assertion SIO_000772 18449568 NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_provenance.
- NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_assertion wasDerivedFrom befree-20150227 NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_provenance.
- NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_assertion wasGeneratedBy ECO_0000203 NP455873.RA-vlnwdM8SN8dgMz1VesFgz7tcCtNDxhSb6y0_dIRPb4130_provenance.